Loading...
Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients
Ascites related to metastatic colorectal cancer (mCRC) reduces patient survival and quality of life, and systemic chemotherapy is largely ineffective for managing ascites. Here, we examined the clinical efficacy of intraperitoneal (IP) ziv-aflibercept for managing refractory ascites in 15 mCRC patie...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482690/ https://ncbi.nlm.nih.gov/pubmed/27888621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13543 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|